Expression of SMAD proteins, TGF-beta/activin signaling mediators, in human thyroid tissues

Sílvia E Matsuo1, Ana Paula Z P Fiore, Simone M Siguematu

  • 1Departamento de Biologia Celular e do Desenvolvimento, Universidade de São Paulo, São Paulo, SP, Brazil.

Abstract

Insights

SMAD protein expression was observed in thyroid tumors. High levels of inhibitory SMAD7 in malignant tumors may reduce the antiproliferative effects of TGF-beta/activin signaling.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Transforming growth factor-beta (TGF-beta)/activin signaling is crucial in cancer, involving SMAD proteins.
  • Phosphorylated SMAD 2 and 3 (pSMAD2/3) with SMAD4 mediate signaling, while SMAD7 inhibits it.
  • Thyroid tumors show high TGF-beta/activin levels despite their antiproliferative role in normal cells.

Purpose of the Study:

  • To investigate SMAD protein expression in human thyroid tissues.
  • To understand the role of SMADs in thyroid tumorigenesis and TGF-beta/activin signaling.

Main Methods:

  • Immunohistochemistry was used to evaluate SMAD protein expression.
  • Tissues analyzed included multinodular goiter, follicular adenoma, papillary, and follicular carcinomas.

Main Results:

  • SMAD proteins (pSMAD2/3, SMAD4, SMAD7) were expressed in benign and malignant thyroid tumors.
  • Carcinomas showed high cytoplasmic staining for pSMAD2/3, SMAD4, and SMAD7.
  • Nuclear pSMAD2/3 staining did not significantly differ between benign and malignant lesions.

Conclusions:

  • SMAD protein expression and nuclear localization of pSMAD2/3 and SMAD4 suggest TGF-beta/activin signaling propagation in thyroid tumors.
  • Elevated SMAD7, particularly in carcinomas, may attenuate the antiproliferative signaling of SMADs, contributing to thyroid cancer progression.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...